Addition of silymarin to renin–angiotensin system blockers in normotensive patients with type 2 diabetes mellitus and proteinuria: a prospective randomized trial

Effect of pentoxifylline on renal outcomes in chronic kidney disease patients: A systematic review and meta-analysis

(2016) Christian Leporini et al.   PHARMACOLOGICAL RESEARCH

Diabetes mellitus as a compelling indication for use of renin angiotensin system blockers: systematic review and meta-analysis of randomized trials

(2016) Sripal Bangalore et al.   BMJ-British Medical Journal

Diabetes mellitus as a compelling indication for use of renin angiotensin system blockers: systematic review and meta-analysis of randomized trials

(2016) Sripal Bangalore et al.   BMJ-British Medical Journal

Update on RAAS Modulation for the Treatment of Diabetic Cardiovascular Disease

(2016) Stella Bernardi et al.   Journal of Diabetes Research

Silymarin in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

(2016) Luminita Voroneanu et al.   Journal of Diabetes Research

Efficacy and safety of combining pentoxifylline with angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker in diabetic nephropathy: a meta-analysis

(2015) Mao-Lu Tian et al.   INTERNATIONAL UROLOGY AND NEPHROLOGY

Diabetic kidney disease: a clinical update from Kidney Disease: Improving Global Outcomes

(2015) Mark E. Molitch et al.   KIDNEY INTERNATIONAL

United States Renal Data System public health surveillance of chronic kidney disease and end-stage renal disease

(2015) Allan J. Collins et al.   Kidney International Supplements

Novel Therapies for Diabetic Kidney Disease

(2014) Radica Z. Alicic et al.   ADVANCES IN CHRONIC KIDNEY DISEASE

Risk Factors for Heart Failure in Patients With Type 2 Diabetes Mellitus and Stage 4 Chronic Kidney Disease Treated With Bardoxolone Methyl

(2014) Melanie P. Chin et al.   JOURNAL OF CARDIAC FAILURE

Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure

(2014) Alberto Ortiz et al.   LANCET

Effect of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on All-Cause Mortality, Cardiovascular Deaths, and Cardiovascular Events in Patients With Diabetes Mellitus

(2014) Jun Cheng et al.   JAMA Internal Medicine

A New Equation to Estimate Glomerular Filtration Rate

(2013) Andrew S. Levey et al.   ANNALS OF INTERNAL MEDICINE

2013 ESH/ESC Guidelines for the management of arterial hypertension

(2013)   EUROPEAN HEART JOURNAL

Effect of Addition of Silymarin to Renin-Angiotensin System Inhibitors on Proteinuria in Type 2 Diabetic Patients With Overt Nephropathy: A Randomized, Double-Blind, Placebo-Controlled Trial

(2012) Mohammad Kazem Fallahzadeh et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Effect of Silymarin (Milk Thistle) on Liver Disease in Patients With Chronic Hepatitis C Unsuccessfully Treated With Interferon Therapy

(2012) Michael W. Fried   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The impact of renin–angiotensin–aldosterone system inhibitors on Type 1 and Type 2 diabetic patients with and without early diabetic nephropathy

(2011) Jennifer A. Hirst et al.   KIDNEY INTERNATIONAL

Comparative Effects of Silymarin and Vitamin E Supplementation on Oxidative Stress Markers, and Hemoglobin Levels Among Patients on Hemodialysis

(2011) Jamshid Roozbeh et al.   RENAL FAILURE

Chronic kidney disease: a public health priority and harbinger of premature cardiovascular disease

(2010) P. Stenvinkel   JOURNAL OF INTERNAL MEDICINE

An integrative view on the role of TGF-β in the progressive tubular deletion associated with chronic kidney disease

(2010) Omar García-Sánchez et al.   KIDNEY INTERNATIONAL

Milk thistle in liver diseases: past, present, future

(2010) Ludovico Abenavoli et al.   PHYTOTHERAPY RESEARCH

Silymarin and milk thistle extract may prevent the progression of diabetic nephropathy in streptozotocin-induced diabetic rats

(2010) Ghazal Vessal et al.   RENAL FAILURE